Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Raltegravir 400 mg (ATC-Code nach WHO: J05AJ01)
Description
The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with § 130a para. 8 SGB V for medicines with the active ingredient Raltegravir 400 mg (ATC code according to WHO: J05AJ01). The contract will be concluded within the framework of an "open house" model, i.e., a contract conclusion is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations will not be conducted and (supply) exclusivity will not be given. It is pointed out that the procurement quantity is unknown, as it depends on the demand and the development of the number of insured persons, the prescription behaviour of doctors and the dispensing and stocking behaviour of public pharmacies. Accordingly, minimum procurement quantities are not guaranteed. Interested pharmaceutical companies can download the participation documents from the project room of the German Tender Portal (DTVP). To do this, an application for access to the project room is required. After the applicant has been released by the contracting authority, the participation documents can be accessed. Absolute confidentiality must be maintained regarding the content of the participation documents - in particular regarding the content of the discount agreement and the discounts mentioned therein. Any full or partial disclosure or provision of contents of the participation documents to or for third parties requires the prior written consent of the contracting authority. If participation is waived, all documents must be destroyed immediately in accordance with data protection regulations. The documents to be submitted are specified in the documents "Cover Letter" and "Explanation of Contract Terms" stored in the project room. Communication, including the transmission of the participation documents, takes place electronically via the tender portal DTVP; details can be found in the aforementioned documents. Any contrary information in the contract notice is due to technical reasons and does not constitute a binding obligation. Participation applications can be submitted for the first time by 4 June 2026. Please refer to the annex "Submission Deadlines" stored in the project room for all further submission deadlines. If the deadline for submission falls on a Saturday, Sunday or a public holiday throughout Germany, the following working day shall take its place. Late submissions will be considered for the next submission deadline. The discount agreement will end, regardless of the date of the contract conclusion, no later than 30 June 2028. The contracting authority reserves the right to terminate the open house procedure prematurely, in particular in the event of the conclusion of exclusive discount agreements; in this case, the already concluded discount agreements will end in accordance with the contractual provisions. According to the contracting authority's experience, exclusive discount agreements usually come into force 8 to 12 months after the publication of the corresponding contract notice in the Supplement to the Official Journal of the European Union.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Angiography supplies – Herzkatheterlabor Kreiskliniken Herford-Bünde
Kreiskliniken Herford-Bünde AöRGermanyAngiography suppliesDeadline in 21 daysPublished on Oct 25, 2026
Germany – Radiotherapy, mechanotherapy, electrotherapy and physical therapy devices – Röntgentherapiesystem
Medizinische Universität Lausitz - Carl Thiem KdöRGermanyRadiotherapy, mechanotherapy, electrotherapy and physical therapy devicesDeadline in 8 daysPublished on Oct 25, 2026
Germany – Pharmaceutical products – Patent_95.1_Aripiprazol_Abilify (Maintena)
GWQ ServicePlus AGGermanyPharmaceutical productsDeadline in 32 daysPublished on Oct 25, 2026
Germany – Miscellaneous medical devices and products – Infusionstechnik - Neubau CARDDIAB
Universitätsklinikum DüsseldorfGermanyMiscellaneous medical devices and productsDevices and instruments for infusionInfusion pumpsDeadline in 29 daysPublished on Oct 25, 2026